Events & Webinars
Explore ASPI’s current event listings, including upcoming monthly webinars and educational sessions on Active Surveillance and related topics.
See the individual event page for timing, speaker information, and registration details. Looking for earlier ASPI sessions and archived recordings? Browse the past sessions below, or visit the ASPI meeting video archive.
Featured Event
Speakers: WHAT WE’LL EXPLORE
For men on Active Surveillance, a Gleason 3+4 diagnosis can raise an important question: does finding some Gleason pattern 4 mean treatment is needed, or might continued Active Surveillance still be reasonable for some patients? In this ASPI program, Dr. Matthew Davenport, Dr. Jesse McKenney, and Dr. Tudor Borza will…
Archive
Speakers: Joe Jones, Wayne Zimmermann, Mike Ondra, Dr. Ming Zhou, and Dr. Kevin Shee
Choosing Active Surveillance can be one of the biggest decisions a man makes after a prostate cancer diagnosis. But there can be another difficult question later on: How do you know when staying on…
Speakers: Dr. Michael Liss, MD, PhD, MAS, MBA, FACS
Could gut health play a role in prostate cancer? Join Dr. Michael Liss for a discussion of the microbiome, current research, and what it may mean for men on Active Surveillance.
Speakers: Dr. Michael Leapman
For men on Active Surveillance, one of the biggest questions is not just whether more testing is possible, but how much testing is really needed. Active Surveillance is meant to help men avoid or…
Speakers: Dr. Jeffrey Tosoian, Dr. Eric Klein, and Dr. Angelo Baccala
For men on Active Surveillance, one of the hardest questions is often not whether more testing is available, but which testing may actually help. As research moves beyond traditional PSA, newer biomarker tests are…
Speakers: Dr. Adam B. Weiner
What really matters when you are trying to live well on Active Surveillance and what may not deserve as much worry as it gets? For many men, Active Surveillance brings a steady flow of…
Speakers: Dr. Paul Schellhammer, Dr. David Nash, Dr. Gil Solomon, Dr. Michal Holub, and Dr. Bruce Leslie
What happens when physicians find themselves on the patient side of prostate cancer? This special ASPI program grew out of a question from one of our webinar attendees, who asked whether doctors are somehow…
Speakers: Dr. John Oliffe, PhD
For many men on Active Surveillance, the hardest part isn’t just the PSA tests or biopsies — it’s the ongoing uncertainty. And even when men move from surveillance to treatment, that emotional distress doesn’t…
Speakers: Dr. Mark Emberton
Not so long ago all men at risk underwent prostate biopsy. The introduction of MRI has meant that close to half of men with high PSAs can safely avoid an unnecessary biopsy. Dr. Mark…
Speakers: Dr. Jonathan Epstein
Understanding Not Only What is Present on Your Pathology Report, But Important Information that Could be Missing or Inaccurate In this educational session, globally renowned uropathologist, Dr. Jonathan Epstein will explain how…
Speakers: Dr. Jim Hu, Dr. Alastair Lamb, and Dr. Badar Mian
The times are changing in prostate cancer diagnosis—especially in how biopsies are performed. Recent research comparing transperineal vs transrectal biopsy points to a major shift in both safety and accuracy. A Changing Standard…
Speakers: Dr. Matthew S. Davenport, Dr. Veeru Kasivisvanathan, and Dr. Benjamin Pockros
Magnetic Resonance Imaging (MRI) has become a vital tool in prostate cancer diagnosis and monitoring. Traditionally, multiparametric MRI (mpMRI) has been the standard, but bi-parametric MRI (bpMRI) is emerging as a simpler, faster,…
Speakers: Dr. Brian T. Helfand, MD, PhD
Benign Prostatic Hyperplasia (BPH), or prostate enlargement, is one of the most common conditions affecting men as they age. But research is rapidly evolving—bringing new options for diagnosis, management, and treatment. What does this…
